PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

Terran Biosciences Inc.

USPTO PatentsView assignee record - 9 granted patents across 10 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Terran ranks #30,363 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 10 technology areas.

#30,363
of 49,997 US assignees by volume
Top 8%
by Innovation Score (54.0/100)
24.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R30363 · US Corporation #30,363 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 9 grants
  • MID-PACK #30,363/49,997
  • PHOTO-FINISH Telling Industries
  • CPC-FOCUS C07D · 10 areas
  • INNOV-PAR 54.0/100
  • CLAIMS-DENSE 24.8 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2023–2025 · 3y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Telling Industries, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Terran’s 54.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Terran

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Terran's Innovation Score is 54.0/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Terran?

Each dot is one of Terran’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Terran’s own 24.8 claims/patent is ABOVE the 14.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Terran vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 8.98.999.1 0102030 Granted patents (volume) Avg claims / patent Telling Industries, LLC - 9, 14.56Telling IndustriesTempus Ex Machina, Inc. - 9, 22.78Tempus Ex MachinaTenaris Connections Limited - 9, 26Tenaris Connectio…TeneoBio, Inc. - 9, 27.56TeneobioTescan Brno s.r.o. - 9, 12.78Tescan Brno s r oTesseract Health, Inc. - 9, 13.67Tesseract HealthTest Rite International Co., Ltd. - 9, 4.78Test Rite Interna…Tetracore, Inc. - 9, 16.56TetracoreTerran Biosciences Inc. - 9, 24.78Terran Biosciences
Terran vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Terran's grants concentrate

Terran Biosciences Inc. is a focused PatentsView assignee: 10 CPC subclasses with 77.8% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2024 (4 grants) versus a trough of 2 in 2023. By volume, Terran sits between Telling Industries, LLC and Tetracore, Inc..

Terran's three-year grant acceleration

Terran Biosciences Inc. shows 6 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Terran's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Terran holds 9 patents at rank #30,382, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Terran

By rank, the assignees closest to #30,382 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Terran's primary technology class.

Terran's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

1.522.533.544.5 202320242025 3
USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table
Terran Biosciences Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2023 2 22.2%
2024 4 44.4%
2025partial year 3 33.3%

Which technologies does Terran Biosciences Inc. patent most?

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Terran Biosciences Inc.'s patent record in context - here's where to go next.

  • Terran Biosciences Inc.'s lead technology class is C07D (Heterocyclic Compounds), 77.8% of its portfolio - see every assignee active in that class. Explore C07D
  • Ranked #30,363 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Terran Biosciences Inc. against Telling Industries, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 54.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.